Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Thursday newspaper round-up: Private rents, NHS drugs, data centre
(Sharecast News) - Average private rents have stopped rising in Great Britain after almost a decade of increases, as more landlords cut their prices to secure a tenant, data shows. The typical advertised private rent outside London for properties coming on to the market remained flat at £1,370 a calendar month in the first three months of 2026, according to the property website Rightmove. It is the first time since 2017 that rents have not increased in the first three months of a year compared with levels at the end of the previous year. - Guardian The owner of the Drax power plant in North Yorkshire received record subsidies of almost £1bn for burning trees to generate electricity in 2025, a climate thinktank has calculated. The company was paid £999m last year for generating about 4.5% of Great Britain's electricity from its biomass plant, costing each household £13 a year, according to analysts at Ember. - Guardian
HP is pushing to investigate the assets of Mike Lynch's widow as it seeks to recoup more than £900m in legal damages. The US technology giant asked the High Court on Wednesday to appoint administrators over Lynch's estate, who would manage the holdings and investigate past transactions. - Telegraph
NHS patients risk prescription shortages within weeks if the US and Iran fail to strike a deal ending the Middle East conflict, drug manufacturers have warned. Medicines UK, which represents companies that make 85pc of all NHS prescriptions, said it was "increasingly concerned that some chemicals and solvents used to manufacture active pharmaceutical ingredients are now in very short supply". - Telegraph
The government has expanded plans to reduce bills for thousands of manufacturers as they face a rise in costs following the outbreak of conflict in the Middle East. Chancellor Rachel Reeves has announced the government will widen access to an initiative designed to lower electricity costs for energy-intensive manufacturers by up to 25 per cent to help businesses "compete, win and create good jobs across the country". - The Times
Britain's first proposed "nationally significant" data centre would be powered by gas, putting the government's ambition to create an AI superpower on a collision course with its net-zero goals. The £2 billion Wapseys Wood data centre in Buckinghamshire would include a new gas-fired power station to provide "a resilient and reliable power supply" for the site, planning documents show. - The Times
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.